Prevacid Share Gains Show Impact Of Prior Authorization – Florida Report
Executive Summary
TAP's Prevacid is one of the big market-share winners under Florida's Medicaid supplemental rebate program, according to an analysis prepared for the state legislature
You may also be interested in...
Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow
Pfizer expects to see a "significant" increase in prescription utilization by seniors once Medicare drug coverage is enacted, CEO Henry McKinnell told securities analysts in New York City June 17
Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow
Pfizer expects to see a "significant" increase in prescription utilization by seniors once Medicare drug coverage is enacted, CEO Henry McKinnell told securities analysts in New York City June 17
Florida Disease Management Report: Programs Save 11%; Rebates Save More
Industry-sponsored disease management services have saved the Florida Medicaid program approximately 11%, according to an analysis prepared for the state legislature